期刊文献+

门冬氨酸钾镁片对高血压病患者胰岛素抵抗和动脉弹性的作用 被引量:1

下载PDF
导出
摘要 目的:探讨口服镁剂对轻中度高血压病患者的胰岛素抵抗和动脉弹性的作用。方法:112例轻中度高血压病患者,服用安慰剂1周后,随机分为门冬氨酸钾镁组76例和乐卡地平组36例,共服药4周,平行观察两组患者服药前后血压、动脉弹性、糖代谢、胰岛素敏感性及红细胞内Mg2+、Ca2+等指标的变化。结果:门冬氨酸钾镁片组治疗后血压降低、胰岛素敏感性升高、红细胞内Mg2+水平增高,小动脉弹性改善(P均<0.05);乐卡地平组治疗后血压和红细胞内Ca2+降低、大动脉弹性指数增加(P<均0.05);服药后门冬氨酸钾镁组空腹胰岛素水平较乐卡地平组降低,胰岛素敏感性较乐卡地平组增高(P均<0.05),而血压、大动脉弹性指数和小动脉弹性指数、空腹血糖各项指标两组之间无统计学的差异(P均>0.05)。结论:高血压病患者服用门冬氨酸钾镁片可能是通过纠正高血压病患者细胞内低Mg2+的状态,降低血压,改善胰岛素抵抗和小动脉弹性。
出处 《陕西医学杂志》 CAS 2009年第2期217-219,共3页 Shaanxi Medical Journal
  • 相关文献

参考文献10

  • 1魏益群.镁与糖尿病[J].国外医学(医学地理分册),2003,24(1):5-8. 被引量:11
  • 2丁兴宇,邢孔庚.门冬氨酸钾镁的药理作用及临床应用[J].数理医药学杂志,2002,15(4):339-340. 被引量:8
  • 3Ma J,,Folsom AR,Melnick SL,et al.Associations of se-rumand dietary magnesium with cardiovascular disease,hypertension diabetes,insulin,and carotid arterial wall thickness:the ARICstudy.Atherosclerosis Riskin Com-munities Study[].Journal of Clinical Epidemiology.1995
  • 4BARBAGALLO M,DOMINGUEZ L J,GALIOTO A,et al.Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X[].Molecular Aspects of Medicine.2003
  • 5Saris NEL,Mervaala E,Karppanen H. et al.Magnesium: an update on physiological, clinical and analytical aspects[].Clinica Chimica Acta.2000
  • 6Mizushima S,Cappuccio FP,Nichols R,et al.Dietary magnesiumintake and blood pressure: a qualitative overview of the observationalstudies[].Journal of Human Hypertension.1998
  • 7Tian H,Ma A,Li C,et al.Correlative factors of insulin resistance in essential hypertension[].Hypertension Research.2000
  • 8Paolisso G,Barbagallo M.Hypertension diabetes mellitus and insulin resistance:therole ofintracellular magnesium[].American Journal of Hypertension.1997
  • 9Glasser P.On arterial physiology, pathophysiology of vascular compliance, and cardiovascular disease[].Heart Disease.2000
  • 10Asmar R,Safar M,Queneau P.Pulse pressure: an important tool in cardiovascular pharmacology and therapeutics[].Drugs.2003

二级参考文献16

  • 1陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1997.487.
  • 2陈新谦 金有豫.新编药物学(第13版)[M].北京:人民卫生出版社,1993.365-366.
  • 3[1]de Valk HW. Magnesium in diabetes mellitus[J]. Neth J Med, 1999,54(4) :139~146.
  • 4[2]Saris NE. Magnesium: An update on physiological, clinical and analytical aspects[J]. Clin Chim Acta, 2000,294(1-2): 1~26.
  • 5[3]Fox C, Ramsoomair D, Carter C, et al. Magnesium: Its proven and potential clinical significance[J]. South Med J,2001,94 (12): 1195~ 1201.
  • 6[4]Kelly GS. Insulin resistance: lifestyle and nutritional interventions[J]. Altern Med Rev, 2000,5(2):109~132.
  • 7[5]de Valk HW, Verkaaik R, van Rijn HJM, et al. Oral magnesium supplementation in insulin-requiring type 2 diabetes patients [J]. Diabetes Med, 1998,15 : 503~507.
  • 8[6]Rattanatagarom W. Magnesium deficiency-induced anorexia in hyperphagic obese Zucker rats[J]. Magnesium Res, 2001,14(3):181~188.
  • 9[7]Whang R. Magnesium and potassium supplemention in the prevention of diabetic vascular disease[J]. Med Hypotheses,2000,55(3) :263~265.
  • 10[8]de Valk HW. Magnesium in medicine: observations and interventions[M]. Thesis, Utrecht University, 1997:75~84.

共引文献17

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部